Taken together, these findings suggest that EGCG can be a potent TRAIL sensitizer via extrinsic apoptotic pathway such as caspase 8 and DR5 activation in colorectal cancer cells [19]. The gene discussed is TNFSF10; the disease is colorectal cancer.